Marshall Wace North America’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $276K | Sell |
1,558
-9,037
| -85% | -$1.6M | ﹤0.01% | 1213 |
|
|
2021
Q2 | $1.71M | Sell |
10,595
-231,254
| -96% | -$37.4M | 0.01% | 834 |
|
|
2021
Q1 | $41.4M | Sell |
241,849
-179,983
| -43% | -$30.8M | 0.17% | 140 |
|
|
2020
Q4 | $92.7M | Buy |
421,832
+405,650
| +2,507% | +$89.1M | 0.42% | 48 |
|
|
2020
Q3 | $2.69M | Buy |
+16,182
| New | +$2.69M | 0.02% | 510 |
|
|
2020
Q2 | – | Sell |
-33,529
| Closed | -$2.58M | – | 1560 |
|
|
2020
Q1 | $2.58M | Buy |
+33,529
| New | +$2.58M | 0.02% | 439 |
|
|
2019
Q3 | – | Sell |
-19,708
| Closed | -$2.03M | – | 1606 |
|
|
2019
Q2 | $2.03M | Buy |
+19,708
| New | +$2.03M | 0.01% | 563 |
|
|
2018
Q4 | – | Sell |
-323,793
| Closed | -$15.3M | – | 1686 |
|
|
2018
Q3 | $15.3M | Sell |
323,793
-480,983
| -60% | -$22.7M | 0.1% | 164 |
|
|
2018
Q2 | $39.7M | Buy |
804,776
+495,017
| +160% | +$24.4M | 0.22% | 109 |
|
|
2018
Q1 | $9.51M | Buy |
309,759
+297,205
| +2,367% | +$9.12M | 0.05% | 409 |
|
|
2017
Q4 | $229K | Sell |
12,554
-124,398
| -91% | -$2.27M | ﹤0.01% | 1268 |
|
|
2017
Q3 | $1.64M | Buy |
+136,952
| New | +$1.64M | 0.01% | 846 |
|